# mtm laboratories

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mtm-laboratories

- Industry: Medical Devices & Equipment
- Headquarters: Heidelberg, Germany
- Website: www.mtm-laboratories.com
- Total disclosed funding: $78M
- Latest round: Series C (Nov 8, 2010)
- Investors on record: 9

## About

mtm laboratories AG specializes in the development and commercialization of innovative diagnostic solutions for cervical cancer screening and other healthcare applications, utilizing advanced technologies to improve patient outcomes.Founded in 1999 and headquartered in Heidelberg, Germany, mtm laboratories AG focuses on innovative diagnostics. The company was acquired by Roche in July 2011 for EUR 130 million, having previously raised a total of EUR 130 million from investors including Heidelberg Innovation Funds Management and others. The firm has completed 7 deals since its founding.mtm laboratories AG provides advanced diagnostic products primarily aimed at the detection of cervical cancer. The company’s offerings include state-of-the-art testing solutions that facilitate early diagnosis and monitoring of diseases, which are crucial for effective treatment. Its products are designed for healthcare providers, hospitals, and laboratories, ensuring they meet the diverse medical needs of patients globally, with significant distribution in Europe and beyond.In 2016, mtm laboratories AG reported revenue of EUR 2,829,611.90 and an EBITDA of EUR 663,273.30, generated through the sale of its diagnostic products directly to healthcare providers and through established distribution channels.Following its acquisition by Roche, mtm laboratories AG plans to leverage Roche's resources to expand its product offerings. The company intends to enhance its diagnostic portfolio with new products aimed at improving cervical cancer screening methods and aims to penetrate additional European and Asian markets by 2023. The strategic use of the recent funding from Roche will support research and development, enabling the launch of innovative solutions that meet the evolving needs of the healthcare sector.

## Funding rounds

- Series C, Nov 8, 2010, $9.6M — Wellington Partners, Heidelberg Innovation Funds Management, HBM Partners, Gilde Healthcare, National Technology Enterprises Company
- Series C, Oct 5, 2009, $25M — HBM Partners, Gilde Healthcare, LBBW Venture Capital
- Series C, Oct 9, 2006, $28M — Wellington Partners, Heidelberg Innovation Funds Management, HBM Partners, NMT Capital, swissfirst Bank
- Series B, Oct 21, 2003, $3.5M — Wellington Partners
- Series B, Apr 1, 2003, $9.8M — Heidelberg Innovation Funds Management, HBM Partners, Forest Roots Capital
- Series A, Aug 1, 1999, $1.6M — Heidelberg Innovation Funds Management, Forest Roots Capital

## Investors

- Heidelberg Innovation Funds Management (https://capitalatlas.ai/funds/heidelberg-innovation-funds-management) — Series A, Series B, Series C
- Forest Roots Capital — Series A, Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B, Series C
- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series B, Series C
- NMT Capital (https://capitalatlas.ai/funds/nmt-capital) — Series C
- swissfirst Bank — Series C
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series C
- LBBW Venture Capital (https://capitalatlas.ai/funds/lbbw-venture-capital) — Series C
- National Technology Enterprises Company — Series C